Sinofn Health
Sinofn Health
As a leading ODM supplier, SINOFN recognizes that the global Coenzyme Q10 (CoQ10) market is shifting. Consumers are increasingly educated on the difference between the two primary forms of this vital coenzyme: Ubiquinone (the oxidized form) and Ubiquinol (the reduced, active form).
Ubiquinone is the standard form found in most conventional supplements. However, it requires a conversion process within the body to become Ubiquinol, which is the form necessary for cellular ATP production and antioxidant protection. As the human body ages, this conversion efficiency declines. At SINOFN, we specialize in high-stability Ubiquinol formulations that bypass this rate-limiting step, offering superior bioavailability for anti-aging, heart health, and energy formulations.
Our position as a premier Chinese manufacturer is not merely about cost-efficiency; it is about technological sovereignty. By leveraging deep partnerships with the Chinese Academy of Sciences (CAS), we control the entire lifecycle of CoQ10 production—from fermentation strain selection to final encapsulation. This vertical integration provides resilience against global market fluctuations, ensuring that our partners receive consistent supply, stringent quality control, and cutting-edge ingredient stability.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services.
During her clinical work, Mrs. Liu witnessed lifelong struggles of PKU children. She founded SINOFN to develop affordable, science-backed solutions.
Led by Dr. Zhang Ying (CAS) and Dr. Tan Shengjie (Peking University), we bridge the gap between medical research and consumer nutrition.
Our GMP production lines, ISO 22000, and HACCP certifications ensure global standard safety and efficacy.
The future of CoQ10 lies in delivery technology. SINOFN is currently piloting nano-emulsion and liposomal encapsulation techniques to further increase the absorption rates of Ubiquinol. Our roadmap includes:
Our competitive advantage lies in the integration of high-level scientific research from the Chinese Academy of Sciences with flexible, large-scale manufacturing. We don't just manufacture; we co-develop.
Absolutely. From raw material sourcing (including high-purity Ubiquinol) to pilot-scale stability testing and full-scale production, we support the entire product development lifecycle.
Our regulatory team ensures that every batch meets the standards of the target market, whether it's US FDA, EU food safety regulations, or local specificities for special medical purpose foods (FSMP).
